| Date | Time | Source | | | 05/23/2013 | 4:55AM | PRNUS | Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaki...
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 PR Newswire SAN DIEGO and PARIS, May 23, 2013 -- Prospective, Multi-Center, Double-Blinded Study Confirms Prior Results in evaluating Volcano's iFR®... More...>> |
| 05/23/2013 | 4:30AM | PRNUS | Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaki...
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 Prospective, Multi-Center, Double-Blinded Study Confirms Prior Results in evaluating Volcano's iFR® (Instant Wave-Free Ratio™) Software Modality... More...>> |
| 05/21/2013 | 3:50PM | ZACKS | Volcano Product Launch at EuroPCR - Analyst Blog
Recently, Volcano Corporation (VOLC) disclosed its plan to feature its innovative technologies, including the company’s Fractional Flow Reserve (FFR) and iFR (Instant Wave-Free Ratio) technologies at the EuroPCR 2013 in Paris. At the EuroPCR, Volcano will also launch its iFR modality and CORE Integrated System. The... More...>> |
| 05/21/2013 | 5:17AM | PRNUS | Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1]
Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1] PR Newswire SAN DIEGO, May 21, 2013 -- Volcano Highlights Two Products Intended to Expand the Role of Physiology in the Cath Lab SAN DIEGO, May 21, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ:... More...>> |
| 05/21/2013 | 4:40AM | PRNUS | Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1]
Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1] Volcano Highlights Two Products Intended to Expand the Role of Physiology in the Cath Lab PR Newswire SAN DIEGO, May 21, 2013 SAN DIEGO, May 21, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ:... More...>> |
| 05/20/2013 | 9:01PM | PRNUS | Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013
Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 PR Newswire SAN DIEGO, May 21, 2013 SAN DIEGO, May 21, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral... More...>> |
| 05/20/2013 | 8:38PM | PRNUS | Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013
Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 PR Newswire SAN DIEGO, May 20, 2013 SAN DIEGO, May 20, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral... More...>> |
| 05/07/2013 | 4:04AM | ZACKS | Volcano Beats Earnings, Downturn Ahead - Analyst Blog
Volcano Corporation (VOLC) reported adjusted earnings per share (EPS) of 2 cents in the first quarter of 2013. The result betters the year-ago break-even level as well as the Zacks Consensus Estimate of a loss of a penny. On a reported basis, the company recorded loss of 6 cents per share in the first quarter of 2013... More...>> |
| 05/02/2013 | 4:05PM | PRNUS | Volcano Announces First Quarter Results
Volcano Announces First Quarter Results PR Newswire SAN DIEGO, May 2, 2013 SAN DIEGO, May 2, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today... More...>> |
| 04/22/2013 | 8:00AM | PRNUS | Volcano Corporation Schedules First Quarter Conference Call, Webcast
Volcano Corporation Schedules First Quarter Conference Call, Webcast PR Newswire SAN DIEGO, April 22, 2013 SAN DIEGO, April 22, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and... More...>> |
| 04/18/2013 | 10:50AM | ZACKS | Volcano Corporation Stays Neutral - Analyst Blog
Recently, we have reaffirmed our Neutral recommendation on Volcano Corporation (VOLC). Although we are concerned about the company’s disappointing fourth quarter 2012 and conservative outlook for 2013, strong pipeline development and encouraging growth trends are expected to offset the near-term challenges of this... More...>> |
| 03/15/2013 | 10:40AM | ZACKS | Volcano Strengthens Portfolio - Analyst Blog
Recently, Volcano Corporation (VOLC) launched its Valet microcatheter in the U.S. and Europe. The company’s latest offering is available in lengths of 100cm, 135cm and 150cm and sizes compatible with 0.014" and 0.035" guidewires. The launch of Valet microcatheter underlines Volcano’s focus on precision... More...>> |
| 03/14/2013 | 8:00AM | PRNUS | Volcano Announces Launch of Valet® Microcatheter in the United States and Europe
Volcano Announces Launch of Valet® Microcatheter in the United States and Europe New Product Line Provides Unsurpassed Precision, Control and Support in Complex Cases PR Newswire SAN DIEGO, March 14, 2013 SAN DIEGO, March 14, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer... More...>> |
| 03/13/2013 | 8:00AM | PRNUS | Axsun Technologies to Present New Products at the 2013 OFC/NFOEC Exhibition
Axsun Technologies to Present New Products at the 2013 OFC/NFOEC Exhibition PR Newswire BILLERICA, Mass., March 13, 2013 BILLERICA, Mass., March 13, 2013 /PRNewswire/ -- Axsun Technologies Inc., a wholly-owned subsidiary of Volcano Corporation (NASDAQ: VOLC) and a leading developer and manufacturer of advanced photonic... More...>> |
| 03/11/2013 | 9:31AM | PRNUS | Critical Alerts For Boeing, Time Warner, Sotheby's, PACCAR, and Volcano Corp. Released By InvestorsObserver
Critical Alerts For Boeing, Time Warner, Sotheby's, PACCAR, and Volcano Corp. Released By InvestorsObserver PR Newswire CHICAGO, March 11, 2013 CHICAGO, March 11, 2013 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BA, TWX, BID, PCAR, and VOLC. (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046... More...>> |
| 03/06/2013 | 10:00AM | GLOBE | Volcano Corporation [VOLC] to Ring The NASDAQ Stock Market Opening Bell
ADVISORY, March 6, 2013 (GLOBE NEWSWIRE) -- What: Volcano Corporation [VOLC] will visit the NASDAQ MarketSite in Times Square. Volcano Corporation develops, manufactures and commercializes a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease... More...>> |
| 03/04/2013 | 8:00AM | PRNUS | Volcano Corporation Announces Presentations At Upcoming Investor Conferences
Volcano Corporation Announces Presentations At Upcoming Investor Conferences PR Newswire SAN DIEGO, March 4, 2013 SAN DIEGO, March 4, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary... More...>> |
| 02/26/2013 | 8:00AM | PRNUS | Volcano Corporation Announces Webcast Of March Seventh Analyst Day
Volcano Corporation Announces Webcast Of March Seventh Analyst Day PR Newswire SAN DIEGO, Feb. 26, 2013 SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral... More...>> |
| 02/22/2013 | 5:20AM | ZACKS | Volcano Reports Dismal 4Q - Analyst Blog
Volcano Corporation (VOLC) reported earnings per share ("EPS") of 4 cents in the fourth quarter of fiscal 2012. The reported result missed the Zacks Consensus Estimate by 5 cents as well as the year-ago EPS of 54 cents. However, if we adjust a portion of the company's deferred tax valuation allowance from... More...>> |
| 02/21/2013 | 10:03PM | PRNUS | Volcano Corporation Provides Additional Guidance For 2013
Volcano Corporation Provides Additional Guidance For 2013 PR Newswire SAN DIEGO, Feb. 21, 2013 SAN DIEGO, Feb. 21, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular... More...>> |
|
